GIL
Gildan Activewear Inc.
GIL offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
NKE
NIKE, Inc.
NKE has the edge over GIL overall, supported by stronger valuation and stronger modeled upside.
GIL Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Weak |
GIL's revenue, profitability and cash flow are currently healthy, but its balance sheet is weak.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
GIL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.2x | $34.83 | — |
| Cheap | 11x | $5.67 | -84% |
| Fair | 17x | $9.22 | -74% |
| Expensive | 24x | $12.73 | -63% |
| Current | 65x | $34.83 | — |
Historical ranges are pointers, not guarantees.
GIL's PE is in its expensive range at 65x. On analysts' estimates for next year's earnings, today's price would be 9.2x, in its cheap range.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over GIL in the historical PE scenario, which offers more potential upside but is not a forecast.
GIL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Decline | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect GIL's earnings to decline, with its revenue and profitability holding steady.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
GIL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.78 | +599% |
| Q3 2025 | $3.13 | +24% |
| Q3 2024 | $2.52 | -3.8% |
| Q2 2024 | $2.43 | -11% |
| Q1 2024 | $2.96 | +10% |
| Q4 2023 | $3.04 | +4.1% |
| Q3 2023 | $2.62 | -22% |
| Q2 2023 | $2.73 | -21% |
| Q1 2023 | $2.69 | -20% |
NKE has the stronger earnings trend. Trailing diluted EPS is down 79% for GIL versus NKE up 7.2%.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
GIL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.5B | +68% |
| Q1 2026 | $1.2B | +64% |
| Q4 2025 | $1.1B | +33% |
| Q3 2025 | $910.6M | +2.2% |
| Q2 2025 | $918.5M | +6.5% |
| Q1 2025 | $711.7M | +2.3% |
| Q4 2024 | $821.5M | +5% |
| Q3 2024 | $891.1M | +2.4% |
GIL has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | -4.9 points |
| Q1 2026 | 5.1% | -13 points |
| Q4 2025 | 17% | -4.6 points |
| Q3 2025 | 21% | N/A |
| Q2 2025 | 22% | +0.1 points |
| Q1 2025 | 18% | +2.2 points |
| Q4 2024 | 22% | +6.7 points |
| Q3 2024 | 22% | +3.8 points |
GIL has the edge over NKE on profitability, with a higher operating margin.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
GIL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $316.5M | +93% |
| Q1 2026 | -$309.9M | -$145.4M |
| Q4 2025 | $280.6M | +65% |
| Q3 2025 | $203.1M | +35% |
| Q2 2025 | $163.7M | +58% |
| Q1 2025 | -$164.5M | -$93.1M |
| Q4 2024 | $169.9M | -16% |
| Q3 2024 | $150.5M | -43% |
GIL has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
GIL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +18K shares |
| 1 year | +23% | +34.4M shares |
| 3 years | +4.1% | +7.3M shares |
| 5 years | -7% | -13.9M shares |
| Available history | -8.9% | -18M shares |
GIL has 185M diluted shares, up 23% from a year ago, despite $109M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $4.8M |
| Q1 2026 | $71.5M |
| Q4 2025 | $3.4M |
| Q3 2025 | $29.4M |
| Q2 2025 | $77.1M |
| Q1 2025 | $87.4M |
| Q4 2024 | $220.6M |
| Q3 2024 | $381.2M |
GIL spent $109M buying back its own shares over the past year, down 86% from the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over GIL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
GIL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 6.4x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 6.1x | High |
| Q3 2025 | 2.2x | Moderate |
| Q3 2024 | 2.1x | Moderate |
| Q2 2024 | 1.8x | Healthy |
| Q1 2024 | 1.6x | Healthy |
| Q4 2023 | 1.4x | Healthy |
GIL's net debt is about 6.4 years of its operating earnings (EBITDA), up from 2.1 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over GIL on leverage, with a lower net debt burden relative to earnings.
GIL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.2 | Oversold |
| Stochastic | 9.3 | Oversold |
GIL's weekly RSI is 26 (oversold) and its Stochastic is 9 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
GIL PE vs Consumer Cyclical Sector
| Metric | GIL | Sector median | Relative |
|---|---|---|---|
| PE | 65x | 18x | 258% above |
| PE % | 96 | 47 | 49 pts above |
GIL is trading at 65x earnings, a 258% premium to the Consumer Cyclical sector's median of 18x.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over GIL on valuation relative to its sector.
GIL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.3 | 11% below |
| 20 week MA | $47.5 | 27% below |
| 50 week MA | $55.7 | 37% below |
| 100 week MA | $53.4 | 35% below |
| 200 week MA | $44.5 | 22% below |
GIL is in a downtrend: it's below all five of its weekly moving averages, and 22% below its 200-week average.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over GIL on trend strength, trading above more of its moving averages.
GIL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.6 | $28.2 | -4.5% |
| 2021 | $28.2 | $40.8 | +44% |
| 2022 | $40.8 | $27.1 | -34% |
| 2023 | $27.1 | $33.1 | +22% |
| 2024 | $33.1 | $46.9 | +42% |
| 2025 | $46.9 | $63.6 | +36% |
| 2026 YTD | $63.6 | $34.8 | -45% |
GIL is down 45% so far in 2026, after finishing higher in four of the previous six years.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has the edge over GIL on returns for 2026, with the stronger performance.